Latest Breaking News On - Advancing fibrosis focused - Page 1 : comparemela.com

Ghent, Belgium-based Agomab Therapeutics, a biotech company, announced on Wednesday that it has closed a $100M (approximately €94.9M).

Felice verduyn van weegenColleen cuffaroIyona rajkomarTim knotnerusFidelity management research companyLife sciencesBelgium based agomab therapeuticsFidelity managementResearch companyDawn biopharmaFibrostenosing crohnAgomab therapeuticsIdiopathic pulmonary fibrosisAdvancing fibrosis focusedChief executive officer